Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 25:34:100631.
doi: 10.1016/j.gore.2020.100631. eCollection 2020 Nov.

Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?

Madison R Klavans  1 , Sarah H Erickson  2 , Susan C Modesitt  1   3
Affiliations
Case Reports

Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?

Madison R Klavans et al. Gynecol Oncol Rep. .

Abstract

Vulvar cancer remains a rare entity and treatment options for advanced disease are limited. This case report highlights the excellent response of two patients with FIGO Stage IV vulvar cancer treated with neoadjuvant paclitaxel/carboplatin/bevacizumab chemotherapy. While definitive conclusions are impossible, neoadjuvant chemotherapy may ultimately prove to be a better initial treatment option for locally advanced disease in terms of quality of life and response compared to the traditional chemoradiation regimens.

Keywords: Advanced vulvar cancer; Bevacizumab; Carboplatin; Neoadjuvant therapy; Paclitaxel.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1A
Fig. 1A
Case 1: Large exophytic vulvar lesion on initial presentation.
Fig. 1B
Fig. 1B
Same lesion following two cycles of neoadjuvant chemotherapy.
Fig. 1C
Fig. 1C
At the completion of six cycles.
Fig. 2A
Fig. 2A
Axial image from CT chest from the patient in case 1 on initial presentation demonstrating the largest pulmonary nodule measuring 14 mm diameter in the right lower lobe.
Fig. 2B
Fig. 2B
Axial image from CT chest following six cycles of paclitaxel/carboplatin/bevacizumab, demonstrating near complete interval resolution of the same right lower lobe nodule.
Fig. 3A
Fig. 3A
Case 2: Initial presentation with necrotic vulvar lesion encompassing the labia, mons, clitoris and perineum.
Fig. 3B
Fig. 3B
Following two cycles of neoadjuvant chemotherapy.
See this image and copyright information in PMC

References

    1. Gray H.J. Advances in vulvar and vaginal cancer treatment. Gynecol. Oncol. 2010;118:3–5. - PubMed
    1. Horowitz N.S. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol. Oncol. 2012;127:141–146. - PubMed
    1. MacLean A.B. Role of angiogenesis in benign, premalignant and malignant vulvar lesions. J. Reprod. Med. 2000;45:609–612. - PubMed
    1. Moore D.H. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol. Oncol. 2012;124:529–533. - PubMed
    1. National Comprehensive Cancer Network. Vulvar Cancer (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/vulvar.pdf (accessed May 8, 2020).

Publication types

LinkOut - more resources